Geneos Wealth Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Geneos Wealth Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.6K	Buy	166 +1	+0.6%	+$30	﹤0.01%	2159
2026 Q1	$4.8K	Hold	165	–	–	﹤0.01%	2168
2025 Q4	$4.33K	Buy	165 +1	+0.6%	+$26	﹤0.01%	2178
2025 Q3	$3.88K	Hold	164	–	–	﹤0.01%	2203
2025 Q2	$3.37K	Buy	164 +1	+0.6%	+$20	﹤0.01%	2683
2025 Q1	$3.34K	Buy	+163	New	+$3.64K	﹤0.01%	2633

Other funds holding IDNA

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geneos Wealth Management's IDNA Position: Q2 2026 in Review

Geneos Wealth Management increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 0.61% in Q2 2026, buying an estimated $30 and bringing the position to 166 shares worth $5.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2159.

Geneos Wealth Management first reported a position in IDNA in Q1 2025 and has held it in 6 quarters since. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

Geneos Wealth Management held 166 shares of iShares Genomics Immunology and Healthcare ETF worth $5.6K as of Q2 2026.
Geneos Wealth Management bought 1 iShares Genomics Immunology and Healthcare ETF share in Q2 2026, an estimated $30.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2159 holding.
Geneos Wealth Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2025 and has held it in 6 quarters since.
66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.